Medication info
Tenere M Sustained-release Tablets 10/500 mg

Tenere M Sustained-release Tablets 10/500 mg

Prescription medicationTabletOral
Ingredient · strength
Teneligliptin Hydrochloride Hydrate›13mg / 1 tabletMetformin Hydrochloride›500mg / 1 tablet
Manufacturer / importer
Nexpharm Korea Co., Ltd.
Appearance
Orange oval sustained-release film-coated tablet
Packaging
30 tablets/bottle
Approval status
Active

MFDS item code 202201496 · Approved 2022.04.08 · Insurance code 662504760

Summary

Main use
Improves blood glucose control in patients with type 2 diabetes
Who takes it
Adults
Adult dose
The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose is adjusted gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablet once daily. Patients taking this medicine 10/750mg or 10/500mg extended-release tablets should take 2 tablets at the same time once daily. For patients who do not achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's existing metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medicine, the dose of this medicine may be started at the patient's existing doses of teneligliptin and metformin. When switching from immediate-release metformin to an extended-release formulation, glycemic control should be closely monitored and dose adjustments made as appropriate. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other antihyperglycemic agents. Because this may cause changes in glycemic control, any changes in the treatment of patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, this medicine should be swallowed whole and not split, crushed, ground, or chewed.

Ingredients

Manufacturer
Nexpharm Korea Co., Ltd.

Efficacy & effects

Improves blood glucose control in patients with type 2 diabetes

View approved original text

This medication is a treatment for patients with type 2 diabetes who have difficulty controlling blood sugar through diet and exercise, which aids in blood sugar management by using teneligliptin and metformin together. Both components work together to effectively lower and control blood sugar levels. This may improve blood sugar control for patients and contribute to the prevention of complications. Therefore, this medication is used for the control of blood sugar in type 2 diabetes.

How to take

Adult dose

The dose of this medicine should be determined based on each patient's current treatment regimen, efficacy, and tolerability. This medicine is generally administered once daily with the evening meal, and the dose is adjusted gradually to reduce gastrointestinal adverse reactions associated with metformin. Take 1 tablet of this medicine 20/1000mg extended-release tablet once daily. Patients taking this medicine 10/750mg or 10/500mg extended-release tablets should take 2 tablets at the same time once daily. For patients who do not achieve adequate glycemic control with metformin monotherapy, the initial dose of this medicine should provide teneligliptin 20 mg once daily and the patient's existing metformin dose. For patients switching from combination therapy with teneligliptin and metformin to this medicine, the dose of this medicine may be started at the patient's existing doses of teneligliptin and metformin. When switching from immediate-release metformin to an extended-release formulation, glycemic control should be closely monitored and dose adjustments made as appropriate. When coadministered with a sulfonylurea, a reduction in the sulfonylurea dose may be considered to reduce the risk of hypoglycemia. The maximum recommended daily dose is teneligliptin 20mg and extended-release metformin 2000mg. The safety and efficacy of this medicine have not been specifically evaluated in patients switching to it from other antihyperglycemic agents. Because this may cause changes in glycemic control, any changes in the treatment of patients with type 2 diabetes should be made under close monitoring. To maintain its extended-release properties, this medicine should be swallowed whole and not split, crushed, ground, or chewed.

Precautions

This medication is used for the treatment of diabetes and contains components that aid in blood sugar control. However, it should not be used in patients with moderate to severe renal impairment or severe heart disease. Additionally, this medication should be temporarily discontinued before tests involving radiologic contrast agents, and resumed only after confirming normal kidney function following the tests. It is also safe not to administer this medication to pregnant women or those who may become pregnant, and to patients with severe liver dysfunction. During the course of taking this medication, symptoms of hypoglycemia may occur, so caution should be exercised, especially when taken with insulin or other diabetes medications. Serious side effects such as acute pancreatitis may emerge, thus immediate medical attention should be sought if severe abdominal pain or vomiting occurs. Rare side effects like interstitial pneumonia, skin rash, and bullous pemphigoid have been reported; thus, if respiratory distress or skin abnormalities develop, prompt consultation with medical professionals is necessary. Furthermore, this medication may lower vitamin B12 levels, so regular blood tests are needed to monitor this. For elderly patients or those with decreased renal function, dosage adjustment and monitoring of kidney function are important, and in cases of acute infection or dehydration, temporary discontinuation of the medication is advised. The medication should also be temporarily stopped before and after surgery, and resumed only after confirming kidney function status. Alcohol consumption can increase the risk of lactic acidosis, so drinking should be avoided during treatment. This medication can interact with specific drugs, so if other medications are being taken, consulting a doctor or pharmacist is crucial. Finally, for the safety of children, this medication should be stored out of reach of children, and it is preferable for pregnant and breastfeeding women to avoid its use.

Side effects

  • Severe lactic acidosis
  • severe hypoglycemia
  • hypoglycemia
  • constipation
  • bowel obstruction
  • liver dysfunction
  • interstitial pneumonia
  • pemphigoid
  • acute pancreatitis
  • dizziness
Show 142 more
  • abdominal bloating
  • abdominal discomfort
  • nausea
  • abdominal pain
  • distension
  • stomatitis
  • gastric polyp
  • colonic polyp
  • duodenal ulcer
  • gastroesophageal reflux disease
  • diarrhea
  • decreased appetite
  • elevated amylase
  • elevated lipase
  • elevated AST(GOT)
  • elevated ALT(GPT)
  • elevated GGT
  • elevated ALP
  • proteinuria
  • ketonuria
  • occult hematuria
  • eczema
  • rash
  • itching
  • allergic dermatitis
  • arthralgia
  • elevated CK(CPK)
  • elevated serum potassium concentration
  • malaise
  • allergic rhinitis
  • elevated serum uric acid
  • peripheral edema
  • herpes zoster
  • limb pain
  • upper abdominal pain
  • gastritis
  • headache
  • upper respiratory tract infection
  • tremor
  • weakness
  • hunger
  • fatigue
  • facial edema
  • dyspepsia
  • nausea
  • viral upper respiratory infection
  • rhinitis
  • cold sweat
  • diabetic retinopathy
  • vision decrease
  • cough
  • pulmonary congestion
  • dyspnea
  • drug overdose
  • benign prostatic hyperplasia
  • headache
  • diarrhea
  • chronic gastritis
  • irritable bowel syndrome
  • fatigue
  • cerebral infarction
  • hyperglycemia
  • liver biopsy
  • neutropenia
  • abnormal blood sugar
  • increased blood sugar
  • increased blood pressure
  • hepatic coma
  • lumbar spinal canal stenosis
  • intervertebral disc protrusion
  • intervertebral disc disorder
  • spinal ligament ossification
  • foraminal stenosis
  • rotator cuff syndrome
  • bladder mass
  • ureteral calculi
  • urinary stones
  • coronary artery disease
  • unstable angina
  • gastroesophageal reflux disease
  • gastric polyps
  • gastritis
  • bile duct obstruction
  • chronic cholecystitis
  • soft tissue infection
  • pneumonia
  • cataract
  • depression
  • iliac artery stenosis
  • vertigo
  • benign prostatic hyperplasia
  • knee surgery
  • urticaria
  • glaucoma
  • blurred vision
  • age-related macular degeneration
  • hyperthyroidism
  • hyperparathyroidism
  • angina
  • otalgia
  • iron deficiency anemia
  • food allergy
  • pressure ulcer
  • vomiting
  • abdominal pain
  • gastrointestinal motility disorder
  • decreased gastrointestinal motility
  • enteritis
  • toothache
  • anal rectal discomfort
  • acquired mixed hyperlipidemia
  • hypertriglyceridemia
  • vitamin D deficiency
  • abnormal weight gain
  • essential hypertension
  • orthostatic hypotension
  • white coat hypertension
  • bleeding
  • increased blood sugar
  • abnormal sputum
  • increased serum creatinine
  • increased blood urea
  • anemia
  • atrial fibrillation
  • hypothyroidism
  • ovarian cyst
  • vulvar itching
  • menopausal symptoms
  • toxic hepatitis
  • non-alcoholic fatty liver disease
  • alcoholic liver disease
  • eyelid damage
  • ligament sprain
  • lip injury
  • bruise
  • headache
  • diabetic neuropathy
  • spinal-cerebral basilar insufficiency
  • foot fracture
  • diarrhea
  • nausea
  • vomiting

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container that does not allow air to enter, ideally at room temperature between 1 and 30 degrees Celsius. Proper storage will help maintain the efficacy of the medication over time.

Appearance and packaging

Appearance

Orange oval sustained-release film-coated tablet

Package unit

30 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.